Biocon Malaysia Plant Fully Operational in 2014, Chairman Says

Biocon Ltd. (BIOS), India’s biggest biotechnology company, expects its Malaysia plant to be fully operational by early 2014, Chairman Kiran Mazumdar-Shaw said in an interview in Kuala Lumpur today.

The plant, in Malaysia’s southern Johor state, will initially manufacture insulin and help guarantee global supply to Pfizer Inc. (PFE), she said. The Bangalore-based group aims to double its share of India’s insulin market to 30 percent, Mazumdar-Shaw said.

To contact the reporter on this story: Gan Yen Kuan in Kuala Lumpur at

To contact the editor responsible for this story: Barry Porter at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.